Page 5 - Nasdaq Rnlx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq rnlx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Rnlx Today - Breaking & Trending Today

Renalytix Reports Full Year Fiscal 2021 Results

LONDON and SALT LAKE CITY, Oct. 21, 2021 (GLOBE NEWSWIRE) Renalytix plc (NASDAQ: RNLX), (LSE: RENX) an artificial intelligence-enabled in vitro. ....

United States , New York , Salt Lake City , University Of Utah , United Kingdom , City Of , Nicholas Moore , Paul Mcmanus Lianne Applegarth , Peter Denardo , James Mccullough , Gary Clarence Daniel Adams , Daniel Levangie , Ann Berman , Us Veterans Administration , Department Of Defense , Atrium Health , Exchange Commission Under Form , Veterans Health Administration , Wake Forest School Of Medicine , York State Department Of Health , Uva Health System , Centers For Medicare Medicaid Services , London Stock Exchange , Services Administration For Kidneyintel , Wake Forest Baptist Health , Indian Health Services ,

Renalytix to Report Financial Results for Fiscal Third

Announces Change of Auditor to Ernst & Young LLP. ....

United Kingdom , Paul Mcmanus Lianne Cawthorne , Us Canada Participant International Dial , Deloitte Touche , Gilmartin Group , Ernst Young , United Kingdom International Dial , Call Details , Canada Participant Toll Free Dial In Number , Canada Participant International Dial In Number , Kingdom International Dial In Number , Kingdom Local Dial In Number , Audit Committee , Kingdom Investor Contact , Mary Kate , Nasdaq Rnlx , Renalytix Ai Plc , ஒன்றுபட்டது கிஂக்டம் , பால் மக்ம்யாநஸ் லியந் காவ்தோர்ன் , எங்களுக்கு கனடா பங்கேற்பாளராக சர்வதேச டயல் செய்யுங்கள் , டெலோய்ட்டே தொடுதல் , கில்மார்டின் குழு , எர்னிஸ்ட இளம் , அழைப்பு விவரங்கள் , கனடா பங்கேற்பாளராக சுங்கவரி இலவசம் டயல் செய்யுங்கள் இல் எண் , கனடா பங்கேற்பாளராக சர்வதேச டயல் செய்யுங்கள் இல் எண் ,

Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure

Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure
Clinical findings published in the April issue of Diabetologia, the official journal of the European Association for the Study of Diabetes
April 05, 2021 07:00 ET
| Source:
Renalytix AI plc.
Renalytix AI plc.
New York, New York, UNITED STATES
NEW YORK, April 05, 2021 (GLOBE NEWSWIRE) RenalytixAI plc (LSE: RENX) (NASDAQ: RNLX), announced today that KidneyIntelX™ more accurately predicted progressive kidney function decline and kidney failure in a multi-center, diverse cohort of 1,146 type 2 diabetes patients with early-stage (stages 1, 2, and 3) kidney disease versus the current standard of care. The results of the study, which is the second peer-reviewed clinical validation study on KidneyIntelX, have been p ....

United States , Michaelj Donovan , Paul Mcmanus Lianne Cawthorne , Marina Basina , Jennifer Moritz , Centers For Disease , European Association For The Study Of Diabetes , Drug Administration , Exchange Commission , Joslin Diabetes Center , Mount Sinai Health System , Stanford Health Care , European Association , Mount Sinai Health , Clinical Professor , Stanford Medicine , Medical Director , Inpatient Diabetes , Stanford Health , United States Medicare , Chief Medical Officer , Kidney Disease , Disease Control , Breakthrough Designation , Private Securities Litigation Reform Act , Nasdaq Rnlx ,

The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health

The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health
Innovative partnership to enable health system-wide approach to help delay or prevent progression in the earliest stages while advancing genetics research for detection, prognosis and treatment of chronic kidney disease
February 24, 2021 08:00 ET
| Source:
Renalytix AI plc.
Renalytix AI plc.
NEW YORK and SALT LAKE CITY, Feb. 24, 2021 (GLOBE NEWSWIRE)
Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, and the
University of Utah, one of the top research institutions in the United States, today announced a partnership to improve kidney health and reduce the risk of kidney failure for large scale populations in the earliest stages of kidney disease. ....

United States , University Of Utah , Katelin Roberts , James Mccullough , John Inadomi , Keith Marmer , University Of Utah School Medicine , Department Of Internal Medicine , University Of Utah Health , University Of Utah Research Park , Outreach Technology , Utah Health , Internal Medicine , Utah School , Research Park , Nasdaq Rnlx , Renalytix Ai Plc , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் உட்டா , கட்டலின் ராபர்ட்ஸ் , ஜேம்ஸ் ம்க்கல , கேய்ட் மார்மேற் , பல்கலைக்கழகம் ஆஃப் உட்டா பள்ளி மருந்து , துறை ஆஃப் உள் மருந்து , பல்கலைக்கழகம் ஆஃப் உட்டா ஆரோக்கியம் , பல்கலைக்கழகம் ஆஃப் உட்டா ஆராய்ச்சி பூங்கா ,